Use

This test assesses sensitization to various inhalant allergens commonly found in the Intermountain West region, including southern Idaho and Nevada. It helps define the allergen responsible for signs and symptoms and confirms sensitization before beginning immunotherapy. This panel can also investigate the specificity of allergic reactions to insect venom allergens, drugs, or chemical allergens. It is not useful for patients previously treated with immunotherapy to determine if residual clinical sensitivity exists or when the medical management does not depend on identifying allergen specificity.